Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

1.

TET proteins in cancer: Current 'state of the art'.

Rawłuszko-Wieczorek AA, Siera A, Jagodziński PP.

Crit Rev Oncol Hematol. 2015 Jul 26. pii: S1040-8428(15)30008-1. doi: 10.1016/j.critrevonc.2015.07.008. [Epub ahead of print] Review.

PMID:
26276226
2.

Thymic emigration patterns in type 2 diabetic patients treated with metformin.

Dworacki G, Urazayev O, Bekmukhambetov Y, Iskakova S, Frycz BA, Jagodziński PP, Dworacka M.

Immunology. 2015 Aug 14. doi: 10.1111/imm.12522. [Epub ahead of print]

PMID:
26271466
3.

EVC gene polymorphisms and risks of isolated hypospadias - a preliminary study.

Kowal A, Mostowska A, Mydlak D, Eberdt-Gołąbek B, Misztal M, Jagodziński PP, Hozyasz KK.

Cent European J Urol. 2015;68(2):257-62. doi: 10.5173/ceju.2015.493. Epub 2015 Jun 18.

4.

Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis.

Roszak A, Misztal M, Sowińska A, Jagodziński PP.

Mol Diagn Ther. 2015 Aug;19(4):235-44. doi: 10.1007/s40291-015-0153-4.

5.

Nucleotide Variants of the BH4 Biosynthesis Pathway Gene GCH1 and the Risk of Orofacial Clefts.

Hozyasz KK, Mostowska A, Wójcicki P, Lasota A, Zadurska M, Dunin-Wilczyńska I, Jagodziński PP.

Mol Neurobiol. 2015 Jul 28. [Epub ahead of print]

PMID:
26215833
6.

Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer.

Słowikowski BK, Gałęcki B, Dyszkiewicz W, Jagodziński PP.

Biomed Pharmacother. 2015 Jul;73:97-101. doi: 10.1016/j.biopha.2015.05.015. Epub 2015 Jun 1.

PMID:
26211588
7.

Association investigation of BACH2 rs3757247 and SOD2 rs4880 polymorphisms with the type 1 diabetes and diabetes long-term complications risk in the Polish population.

Wegner M, Mostowska A, Araszkiewicz A, Choudhury M, Piorunska-Stolzmann M, Zozulinska-Ziolkiewicz D, Wierusz-Wysocka B, Jagodzinski PP.

Biomed Rep. 2015 May;3(3):327-332. Epub 2015 Feb 10.

8.

Relative levels of let‑7a, miR‑17, miR‑27b, miR‑125a, miR‑125b and miR‑206 as potential molecular markers to evaluate grade, receptor status and molecular type in breast cancer.

Lehmann TP, Korski K, Gryczka R, Ibbs M, Thieleman A, Grodecka-Gazdecka S, Jagodziński PP.

Mol Med Rep. 2015 Sep;12(3):4692-702. doi: 10.3892/mmr.2015.4002. Epub 2015 Jun 26.

PMID:
26130254
9.

Increased 17ß-hydroxysteroid dehydrogenase type 1 levels in primary cervical cancer.

Tomaszewska A, Roszak A, Pawlik P, Sajdak S, Jagodziński PP.

Biomed Pharmacother. 2015 May;72:179-83. doi: 10.1016/j.biopha.2015.04.018. Epub 2015 May 8.

PMID:
26054693
10.

Association between polymorphisms at the GREM1 locus and the risk of nonsyndromic cleft lip with or without cleft palate in the Polish population.

Mostowska A, Hozyasz KK, Wójcicki P, Żukowski K, Dąbrowska A, Lasota A, Zadurska M, Radomska A, Dunin-Wilczyńska I, Jagodziński PP.

Birth Defects Res A Clin Mol Teratol. 2015 Jun 4. doi: 10.1002/bdra.23391. [Epub ahead of print]

PMID:
26043427
11.

Polymorphic variants in the dopamine receptor D2 in women with endometriosis-related infertility.

Szczepańska M, Mostowska A, Wirstlein P, Skrzypczak J, Misztal M, Jagodziński PP.

Mol Med Rep. 2015 Aug;12(2):3055-60. doi: 10.3892/mmr.2015.3733. Epub 2015 May 6.

PMID:
25955176
12.

Expression of 17β-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer.

Frycz BA, Murawa D, Borejsza-Wysocki M, Marciniak R, Murawa P, Drews M, Jagodziński PP.

Biomed Pharmacother. 2015 Mar;70:24-7. doi: 10.1016/j.biopha.2014.12.042. Epub 2015 Jan 9.

PMID:
25776474
13.

Stromal cell-derived factor-1 G801A polymorphism and the risk factors for cervical cancer.

Roszak A, Misztal M, Sowińska A, Jagodziński PP.

Mol Med Rep. 2015 Jun;11(6):4633-8. doi: 10.3892/mmr.2015.3315. Epub 2015 Feb 6.

PMID:
25672413
14.

TNF-308 G/A polymorphism and risk of systemic lupus erythematosus in the Polish population.

Piotrowski P, Wudarski M, Sowińska A, Olesińska M, Jagodziński PP.

Mod Rheumatol. 2015 Sep;25(5):719-23. doi: 10.3109/14397595.2015.1008778. Epub 2015 Jun 17.

PMID:
25661739
15.

TNF-α -308 G/A as a risk marker of cervical cancer progression in the Polish population.

Roszak A, Misztal M, Sowińska A, Jagodziński PP.

Mol Diagn Ther. 2015 Feb;19(1):53-7. doi: 10.1007/s40291-015-0130-y.

PMID:
25614219
16.
17.

Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.

Drzewiecka H, Gałęcki B, Jarmołowska-Jurczyszyn D, Kluk A, Dyszkiewicz W, Jagodziński PP.

Lung Cancer. 2015 Feb;87(2):107-16. doi: 10.1016/j.lungcan.2014.12.012. Epub 2014 Dec 25.

PMID:
25564397
18.

Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.

Rawłuszko-Wieczorek AA, Siera A, Horbacka K, Horst N, Krokowicz P, Jagodziński PP.

J Cancer Res Clin Oncol. 2015 Aug;141(8):1379-92. doi: 10.1007/s00432-014-1901-2. Epub 2015 Jan 4.

19.

WNT10A coding variants and maxillary lateral incisor agenesis with associated dental anomalies.

Mostowska A, Biedziak B, Zadurska M, Matuszewska-Trojan S, Jagodziński PP.

Eur J Oral Sci. 2015 Feb;123(1):1-8. doi: 10.1111/eos.12165. Epub 2014 Dec 29.

PMID:
25545742
20.

Clinical aspects of vitamin D-binding protein gene polymorphisms in hemodialysis patients.

Grzegorzewska AE, Ostromecki G, Mostowska A, Sowińska A, Jagodziński PP.

Pol Arch Med Wewn. 2015;125(1-2):8-17. Epub 2015 Dec 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk